Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligi...
ILC is understudied and poorly understood, and requires substantive measures to accelerate research.
- Research in the lab will help to better understand the biology of ILC that can lead to prevention and targeted therapies.
- Clinical trials that are ILC specific or enriched with ILC patients can lead to refined screening, treatments and follow-up care for patients.
Patients who are in cancer treatment, have undergone treatment or are living with lobular breast cancer can help advance our understanding of the disease by participating in clinical trials and research studies.